Foghorn Therapeutics Inc. Quarterly Assets in USD from Q4 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Foghorn Therapeutics Inc. quarterly Assets history and growth rate from Q4 2019 to Q3 2024.
Foghorn Therapeutics Inc. Assets for the quarter ending September 30, 2024 was $308M, a 1.61% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$308M	-$5.05M	-1.61%	Sep 30, 2024	10-Q	2024-11-04
Q2 2024	$329M	-$11M	-3.24%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$255M	-$118M	-31.6%	Mar 31, 2024	10-Q	2024-05-06
Q4 2023	$286M	-$119M	-29.4%	Dec 31, 2023	10-Q	2024-11-04
Q3 2023	$313M	-$121M	-27.8%	Sep 30, 2023	10-Q	2023-11-02
Q2 2023	$340M	-$117M	-25.7%	Jun 30, 2023	10-Q	2023-08-04
Q1 2023	$373M	-$115M	-23.6%	Mar 31, 2023	10-Q	2023-05-08
Q4 2022	$405M	-$115M	-22.1%	Dec 31, 2022	10-K	2024-03-07
Q3 2022	$434M	+$248M	+133%	Sep 30, 2022	10-Q	2022-11-08
Q2 2022	$457M	+$248M	+119%	Jun 30, 2022	10-Q	2022-08-09
Q1 2022	$488M	+$258M	+112%	Mar 31, 2022	10-Q	2022-05-09
Q4 2021	$520M	+$264M	+103%	Dec 31, 2021	10-K	2023-03-09
Q3 2021	$186M	+$43.6M	+30.6%	Sep 30, 2021	10-Q	2021-11-09
Q2 2021	$209M			Jun 30, 2021	10-Q	2021-08-10
Q1 2021	$230M			Mar 31, 2021	10-Q	2021-05-11
Q4 2020	$256M	+$233M	+1044%	Dec 31, 2020	10-K/A	2022-08-09
Q3 2020	$142M			Sep 30, 2020	10-Q	2020-12-04
Q4 2019	$22.3M			Dec 31, 2019	10-K	2021-03-18

* An asterisk sign (*) next to the value indicates that the value is likely invalid.